Trelegy Ellipta, Fluticasone Furoate, Umeclidinium, And Vilanterol, Inhalation Powder, 100/62.5/25 Mcg - 1 Device

Product Name

• Trelegy Ellipta Powder 100/62.5/25 Mcg Device

Scientific Name

• Fluticasone furoate, Umeclidinium bromide, and Vilanterol trifenatate

Category Of Trelegy Ellipta Powder 100/62.5/25 Mcg Device

• Asthma and COPD medications

Mechanism Of Action Of Fluticasone furoate, Umeclidinium bromide, and Vilanterol trifenatate

• Combines corticosteroid, anticholinergic, & β2-agonist. It reduces inflammation, prevents bronchospasm & dilates bronchi.

Therapeutic Indications Of  Trelegy Ellipta Powder 100/62.5/25 Mcg Device

• Used in case of:

1. COPD Maintenance
2. Asthma Management
3. Bronchitis
4. Emphysema

Method Of Administration Of Trelegy Ellipta Powder 100/62.5/25 Mcg Device

• Inhaled orally once daily.
• Doses may be changed in special conditions so always follow your doctor's or pharmacist's instructions.
• If you take more than you should, talk to a doctor or go to the hospital straight away.
• If you forget to take a dose, take it as soon as you remember it unless it is nearly time for your next dose.
• Do not take a double dose (two doses at the same time) to make up for the forgotten dose.

Undesirable Side Effects Of Trelegy Ellipta Powder 100/62.5/25 Mcg Device

• Like all medicines, this medicine can cause side effects, although not everybody gets them, but you may suffer from:

1. Headache.
2. Upper respiratory tract infection.
3. Bronchitis.

Pregnancy & Breastfeeding Precautions While Taking Trelegy Ellipta Powder 100/62.5/25 Mcg Device

• If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
• Your doctor will discuss the possible risks and benefits of using this medicine during pregnancy and breast-feeding

Non-Pharmacological Treatments & Advice For Chronic Obstructive Pulmonary Disease (COPD)

• Quit smoking, the most significant cause of COPD and its progression.
• Avoid second-hand smoke and other lung irritants like dust and strong odors.
• Engage in regular, gentle exercises to improve lung capacity.
• Use air purifiers to maintain indoor air quality.
• Maintain a balanced diet with foods rich in antioxidants.
• Stay updated with vaccinations like flu and pneumonia to avoid complications.
• Engage in pulmonary rehabilitation programs.
• Use breathing techniques such as pursed-lip breathing to improve oxygen exchange.
• Monitor air quality forecasts and stay indoors during poor air quality days.
• Elevate the head while sleeping to ease breathing.

Warnings & Special Precautions while Taking Trelegy Ellipta Powder 100/62.5/25 Mcg Device

• Not for acute bronchospasm.
• May cause urinary retention.
• Monitor for signs of pneumonia in COPD patients.

Storage Conditions Of Trelegy Ellipta Powder 100/62.5/25 Mcg Device

• Store at room temperature below 30°C.
• Keep this medicine out of the sight and reach of children.
• Store in the original package to protect it from moisture.
• Do not use this medicine after the expiry date which is stated on the box/blisters/label. The expiry date refers to the last day of the month.

For More Information About Fluticasone furoate, Umeclidinium bromide, and Vilanterol trifenatate

• Ask your physician or pharmacist
• Visit Drugs.com at: Click here
• Visit WebMD at: Click here
• Visit SFDA at: Click here